A survey of anti-fungal management in lung transplantation.
about
Nebulised amphotericin B to eradicate Candida colonisation from the respiratory tract in critically ill patients receiving selective digestive decontamination: a cohort studyIntrapulmonary pharmacokinetics and pharmacodynamics of micafungin in adult lung transplant patientsCanadian clinical practice guidelines for invasive candidiasis in adults.Critical care perspective on immunotherapy in lung transplantation.Increased mortality after pulmonary fungal infection within the first year after pediatric lung transplantation.Periodontal treatment considerations for cell transplant and organ transplant patients.Invasive fungal infections and antifungal therapies in solid organ transplant recipients.Diagnosis and outcome of early pleural space infection following lung transplantation.Prophylactic antifungal agents used after lung transplantation.Antifungal prophylaxis in solid organ transplant recipients.Invasive fungal infections in lung transplant recipients not receiving routine systemic antifungal prophylaxis: 12-year experience at a university lung transplant center.Lung transplant infection.Anti-Aspergillus Prophylaxis in Lung Transplantation: A Systematic Review and Meta-analysis.Pediatric lung transplantation: promise being realized.Variation in antifungal prophylaxis strategies in lung transplantation.Practice variation in Aspergillus prophylaxis and treatment among lung transplant centers: a national survey.Inhaled voriconazole for prevention of invasive pulmonary aspergillosis.In vivo efficacy of aerosolized nanostructured itraconazole formulations for prevention of invasive pulmonary aspergillosis.Antifungal management practices in liver transplant recipients.Use of prophylactic voriconazole for three months after lung transplantation does not reduce infection with Aspergillus: a retrospective study of 147 patients.Antifungal prophylaxis in pediatric lung transplantation: an international multicenter survey.Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective studyAntifungal Prophylaxis in Lung Transplantation-A World-wide Survey
P2860
Q33750223-E8C69D36-BA08-4973-AE96-EC1DBAD66D6AQ34045450-B4353997-F188-4834-B1AA-C980DEDD0D8FQ34237335-DE01DE9B-EFE8-49B1-A740-FD5C5A9B9891Q36649380-240F4EFE-0113-4AFB-B089-3787FEBAF852Q36748862-F6508074-4AFB-4FE6-AB60-93324E7C7065Q36809175-6AF61659-FAE3-42D5-87AA-2999AAD770B7Q36872848-B5B28F9E-BEBC-4F7B-8432-25EB94D663B1Q37066044-529F027A-6E1A-4B00-84C9-75CA823AD813Q37697380-8153833D-C81C-4D9E-BCC9-097C70161C49Q37879201-C058C388-1F27-467F-9B13-4F796F00D18CQ37933366-11D6B094-420B-4CF8-ACB5-60B5F30050BFQ38010486-64D584B5-6E10-4470-BD32-5E73381E9C00Q38156666-9256B9FA-EA81-4ADF-BEFC-01CEA72D8C1AQ38204614-7D9E8AAE-C23F-4477-A7E3-FEE70207D0C5Q40268302-B6DD539D-853D-4DBE-8802-27D835EE63DDQ41522687-AA628EED-5268-4621-9BBF-DA58EA9D1F04Q42104105-392E9BAB-D1AD-40B4-823E-0B82E3568776Q42107363-2C033990-77E7-4FAA-9DAF-0DD2AF1FFE4DQ46812014-8FC55950-27E6-4F86-BFE4-8A730AB36D35Q50927538-268637B7-1A9D-4750-A26A-DE8D64987758Q53090356-21222542-281E-4429-8BBC-1A24B0F7050DQ57053359-5BF5C3BE-0D6D-4350-885B-B992F49DAF14Q57746212-7C9F0C43-F2D8-47E2-AAA7-867021DEA001
P2860
A survey of anti-fungal management in lung transplantation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
A survey of anti-fungal management in lung transplantation.
@en
type
label
A survey of anti-fungal management in lung transplantation.
@en
prefLabel
A survey of anti-fungal management in lung transplantation.
@en
P2093
P1476
A survey of anti-fungal management in lung transplantation.
@en
P2093
Aaron P Milstone
J Stephen Dummer
Jean Barnes
Mathew Ninan
Nikoloz Lazariashvilli
P304
P356
10.1016/J.HEALUN.2003.09.028
P577
2004-12-01T00:00:00Z